UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  August 6, 2014

_______________________

BioLife Solutions, Inc.
(Exact name of registrant as specified in its charter)
_______________________
 
Delaware 0-18710 94-3076866
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number)
 
3303 Monte Villa Parkway
Bothell, Washington 98021
(Address of principal executive offices, including zip code)

 (425) 402-1400
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
 o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
 o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
 o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.24d-2(b))
     
 o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.23e-4(c))
     
 
 


 
 
 
 
 
Item 5.07                      Submission of Matters to a Vote of Security Holders.
 
On August 6, 2014, BioLife Solutions, Inc. (the “Company”) held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”) at its principal executive office in Bothell, Washington. At the Annual Meeting, the Company’s stockholders approved each of the following proposals set forth in the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on June 20, 2014:

Proposal 1:

The Company’s stockholders elected the following directors to hold office until the 2015 Annual Meeting:
 
Name
 
Votes For
   
Votes Withheld
   
Broker Non-Votes
 
Michael Rice
    6,704,684       116,417       2,953,159  
Raymond Cohen
    6,722,732       98,369       2,953,159  
Andrew Hinson
    6,802,131       18,970       2,953,159  
Joseph Schick
    6,802,169       18,932       2,953,159  
Rick Stewart
    6,802,212       18,889       2,953,159  
 
Proposal 2:
 
The Company’s stockholders ratified the appointment of Peterson Sullivan LLP as our independent registered public accounting firm for 2014, as set forth below:
 
Votes For
 
Votes Against
 
Abstain
 
Broker Non-Votes
 6,696,633    44,591    22,778    2,953,159
 
 
2

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  BIOLIFE SOLUTIONS, INC.  
       
Dated: August 8, 2014
By:
/s/ Daphne Taylor  
    Daphne Taylor  
    Chief Financial Officer  
       

3